SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-068376
Filing Date
2021-03-04
Accepted
2021-03-04 06:07:59
Documents
9
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d15126d6k.htm 6-K 17350
2 EX-1.1 d15126dex11.htm EX-1.1 279271
3 EX-5.1 d15126dex51.htm EX-5.1 21964
4 EX-99.1 d15126dex991.htm EX-99.1 9562
5 EX-99.2 d15126dex992.htm EX-99.2 9664
6 GRAPHIC g15126dsp0001.jpg GRAPHIC 3483
7 GRAPHIC g15126dsp0002.jpg GRAPHIC 1263
8 GRAPHIC g15126g0304015151773.jpg GRAPHIC 6791
9 GRAPHIC g15126g0304015647916.jpg GRAPHIC 6782
  Complete submission text file 0001193125-21-068376.txt   364690
Mailing Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920
Business Address 83 CLEMENCEAU AVENUE #12-03 UE SQUARE SINGAPORE U0 239920 65 6222 4235
ASLAN Pharmaceuticals Ltd (Filer) CIK: 0001722926 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38475 | Film No.: 21712468
SIC: 2834 Pharmaceutical Preparations